New insights from uncultivated genomes of the global human gut microbiome DOI Creative Commons
Stephen Nayfach, Zhou Jason Shi, R. Seshadri

et al.

Nature, Journal Year: 2019, Volume and Issue: 568(7753), P. 505 - 510

Published: March 13, 2019

The genome sequences of many species the human gut microbiome remain unknown, largely owing to challenges in cultivating microorganisms under laboratory conditions. Here we address this problem by reconstructing 60,664 draft prokaryotic genomes from 3,810 faecal metagenomes, geographically and phenotypically diverse humans. These provide reference points for 2,058 newly identified species-level operational taxonomic units (OTUs), which represents a 50% increase over previously known phylogenetic diversity sequenced bacteria. On average, OTUs comprise 33% richness 28% abundance per individual, are enriched humans rural populations. A meta-analysis clinical gut-microbiome studies pinpointed numerous disease associations OTUs, have potential improve predictive models. Finally, our analysis revealed that uncultured undergone reduction has resulted loss certain biosynthetic pathways, may offer clues improving cultivation strategies future. Draft metagenomes populations enrich understanding identifying two thousand new taxa associations.

Language: Английский

Immunology in the liver — from homeostasis to disease DOI
Felix Heymann, Frank Tacke

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2016, Volume and Issue: 13(2), P. 88 - 110

Published: Jan. 13, 2016

Language: Английский

Citations

1016

SCFA: mechanisms and functional importance in the gut DOI Open Access
Camille Martin‐Gallausiaux, Ludovica Marinelli, Hervé M. Blottière

et al.

Proceedings of The Nutrition Society, Journal Year: 2020, Volume and Issue: 80(1), P. 37 - 49

Published: April 2, 2020

In recent years, the importance of gut microbiota in human health has been revealed and many publications have highlighted its role as a key component physiology. Owing to use modern sequencing approaches, characterisation microbiome healthy individuals disease demonstrated disturbance microbiota, or dysbiosis, associated with pathological conditions. The establishes symbiotic crosstalk their host: commensal microbes benefit from nutrient-rich environment provided by produces hundreds proteins metabolites that modulate functions host, including nutrient processing, maintenance energy homoeostasis immune system development. Many bacteria-derived originate dietary sources. Among them, an important attributed derived bacterial fermentation fibres, namely SCFA linking host nutrition intestinal maintenance. are fuels for epithelial cells (IEC) regulate IEC through different mechanisms proliferation, differentiation well subpopulations such enteroendocrine cells, impact motility strengthen barrier metabolism. Recent findings show SCFA, particular butyrate, also immuno-modulatory functions. this review, we discuss on immunity consequently health.

Language: Английский

Citations

946

Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability DOI
Moran Yassour, Tommi Vatanen, Heli Siljander

et al.

Science Translational Medicine, Journal Year: 2016, Volume and Issue: 8(343)

Published: June 15, 2016

The gut microbial community is dynamic during the first 3 years of life, before stabilizing to an adult-like state. However, little known about impact environmental factors on developing human microbiome. We report a longitudinal study microbiome based DNA sequence analysis monthly stool samples and clinical information from 39 children, half whom received multiple courses antibiotics life. Whereas most children born by vaginal delivery was dominated Bacteroides species, four cesarean section 20% vaginally lacked in 6 18 months Longitudinal sampling, coupled with whole-genome shotgun sequencing, allowed detection strain-level variation as well abundance antibiotic resistance genes. microbiota antibiotic-treated less diverse terms both bacterial species strains, some often single strains. In addition, we observed short-term composition changes between consecutive treated antibiotics. Antibiotic genes carried chromosomes showed peak after treatment followed sharp decline, whereas mobile elements persisted longer therapy ended. Our results highlight value high-density sampling studies high-resolution strain profiling for studying establishment response perturbation infant

Language: Английский

Citations

930

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease DOI Creative Commons
Rohit Loomba, Victor Seguritan, Weizhong Li

et al.

Cell Metabolism, Journal Year: 2017, Volume and Issue: 25(5), P. 1054 - 1062.e5

Published: May 1, 2017

Language: Английский

Citations

926

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives DOI Creative Commons

Natascha Roehlen,

Émilie Crouchet,

Thomas F. Baumert

et al.

Cells, Journal Year: 2020, Volume and Issue: 9(4), P. 875 - 875

Published: April 3, 2020

Liver fibrosis due to viral or metabolic chronic liver diseases is a major challenge of global health. Correlating with disease progression, key factor for outcome and risk hepatocellular carcinoma (HCC). Despite different mechanism primary injury disease-specific cell responses, the progression fibrotic follows shared patterns across main etiologies. Scientific discoveries within last decade have transformed understanding mechanisms fibrosis. Removal elimination causative agent such as control cure infection has shown that reversible. However, reversal often occurs too slowly infrequent avoid life-threatening complications particularly in advanced Thus, there huge unmet medical need anti-fibrotic therapies prevent HCC development. while many candidate agents robust effects experimental animal models, their clinical trials been limited absent. no approved therapy exists In this review we summarize cellular drivers molecular fibrogenesis discuss impact development urgently needed therapies.

Language: Английский

Citations

862

The intestinal microbiota fuelling metabolic inflammation DOI
Herbert Tilg, Niv Zmora, Timon E. Adolph

et al.

Nature reviews. Immunology, Journal Year: 2019, Volume and Issue: 20(1), P. 40 - 54

Published: Aug. 6, 2019

Language: Английский

Citations

806

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders DOI
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes

et al.

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2020, Volume and Issue: 17(5), P. 279 - 297

Published: March 9, 2020

Language: Английский

Citations

787

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome DOI

Erin M. Hill‐Burns,

Justine W. Debelius, James T. Morton

et al.

Movement Disorders, Journal Year: 2017, Volume and Issue: 32(5), P. 739 - 749

Published: Feb. 14, 2017

There is mounting evidence for a connection between the gut and Parkinson's disease (PD). Dysbiosis of microbiota could explain several features PD.

Language: Английский

Citations

766

The Human Microbiota in Health and Disease DOI Creative Commons
Baohong Wang, Mingfei Yao, Longxian Lv

et al.

Engineering, Journal Year: 2017, Volume and Issue: 3(1), P. 71 - 82

Published: Feb. 1, 2017

Trillions of microbes have evolved with and continue to live on within human beings. A variety environmental factors can affect intestinal microbial imbalance, which has a close relationship health disease. Here, we focus the interactions between microbiota host in order provide an overview role basic biological processes development progression major diseases such as infectious diseases, liver gastrointestinal cancers, metabolic respiratory mental or psychological autoimmune diseases. We also review important advances techniques associated research, DNA sequencing, metabonomics, proteomics combined computation-based bioinformatics. Current research become much more sophisticated comprehensive. Therefore, propose that should host-microbe interaction cause-effect mechanisms, could pave way understanding gut disease, new therapeutic targets treatment approaches clinical practice.

Language: Английский

Citations

761

Alcoholic liver disease: mechanisms of injury and targeted treatment DOI
Alexandre Louvet, Philippe Mathurin

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2015, Volume and Issue: 12(4), P. 231 - 242

Published: March 17, 2015

Language: Английский

Citations

756